ABSTRACT
Objetivo: Caracterizar las disfunciones sexuales y estimar la prevalencia en un grupo de mujeres en transición a la menopausia, así como evaluar la frecuencia de la sintomatología climatérica. Método: Estudio de corte transversal, entre 2017 y 2020, que incluyó 411 mujeres en transición a la menopausia, residentes en el Quindío, con pareja estable y actividad sexual en las últimas 6 semanas. Se utilizó como instrumento el FSFI-6 (6-Item Female Sexual Function Index). Resultados: La edad promedio fue de 46,53 ± 2,87 años. La prevalencia de disfunciones sexuales fue del 38,92%, caracterizadas por dificultades con el deseo sexual (38,92%), seguido de dolor/dispareunia (35,52%). El promedio general en la puntuación del FSFI-6, en la totalidad de la población participante, fue de 22,29 ± 0,84 puntos; en la población afectada (< 19 puntos) fue de 15,78 ± 3,94. En los dominios, la puntuación más baja estuvo en el deseo (3,14 ± 0,56). La mediana de disfunciones sexuales por mujer fue de tres (23,84%). Conclusiones: más de un tercio de las mujeres del Quindío en transición a la menopausia presentan disfunciones sexuales; el trastorno más común fue el bajo deseo. Se deben hacer esfuerzos para aumentar la conciencia en los asuntos de salud sexual.
Objective: To characterize sexual dysfunctions and estimate the prevalence in a group of women in transition to menopause, as well as to evaluate the frequency of climacteric symptoms. Method: Cross-sectional study, between 2017 and 2020, included 411 women in transition to menopause, residents of Quindío, with a stable partner and sexual activity in the last 6 weeks. The FSFI-6 (6-Item Female Sexual Function Index) was used as an instrument. Results: The mean age was 46.53 ± 2.87 years. The prevalence of sexual dysfunctions was 38.92%, characterized by difficulties with sexual desire (38.92%), followed by pain/dyspareunia (35.52%). The general average, in the FSFI-6 score, in the entire participating population, was 22.29 ± 0.84 points; while in the affected population (< 19 points), it was 15.78 ± 3.94. In the domains, the lowest score was in desire (3.14 ± 0.56). The median number of sexual dysfunctions per woman was three (present in 23.84%). Conclusions: This study showed that more than one third of the women in Quindío, in transition to menopause, had sexual dysfunctions; the most common type of disorder was low desire. Efforts should be made to increase awareness about sexual health issues.
Subject(s)
Humans , Female , Sexual Dysfunction, Physiological/etiology , Menopause/psychology , Sexual Behavior , Sexual Dysfunction, Physiological , Surveys and Questionnaires , DyspareuniaABSTRACT
Abstract Background People with multiple sclerosis (PwMS) show an increased risk of sexual dysfunction (SD), both in women and men. Objective The aim of the present study was to apply the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 (MSISQ-19) and evaluate our results by comparing them with those in in the literature, as well as to assess the ease of applying the scale and the engagement of the patients in discussing the topic of sexuality. Methods We developed and applied a web-based Google form questionnaire that the respondents completed online, which included the MSISQ-19, for the assessment of sexual function. Baseline characteristics were reported as proportions and mean ± standard deviation (SD) or median ± interquartile range (IQR) as appropriate according to data distribution. Categorical variables were stratified by sex and compared with chisquared tests. Statistical analyses were performed using STATA v. 16 (StataCorp., College Station, TX, USA). Results Of the 621 respondents, 541 were included in the analysis. Among the patients with MS, a total of 347 (64.14%) exhibited SD. When stratified by gender, the frequencies of SD were not significantly different. Conclusion There is a high incidence of sexual dysfunction among PwMS and we need to identify the reasons for this and implement strategies to treat and counsel our patients. The MSISQ-19 can be used to help clinicians to assess sexual functioning in a quick and easy way and give patients the possibility to address this topic and receive appropriate help and support.
Resumo Antecedentes Pacientes com esclerose múltipla apresentam altas taxas de disfunção sexual em diversos estudos. Objetivo Avaliar a aplicação e resultados da ferramenta para avaliação de disfunção sexual em pacientes com Esclerose Multipla, Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 (MSISQ-19), bem como comparar os resultados encontrados com a literatura já existente e ter a percepção do engajamento dos pacientes sobre o tema. Métodos Realizado através de questionário on-line na plataforma Google Forms, composto por questões sobre perfil demográfico e relacionadas à doença e o questionário MSISQ-19. Os dados demográficos e sobre a doença foram descritos como proporções e média ± desvio padrão (DP) ou mediana ± intervalo interquartil (IIQ). As variáveis categóricas foram estratificadas por sexo e comparadas com testes de qui-quadrado. As análises estatísticas foram realizadas no programa STATA v. 16 (StataCorp., College Station, TX, EUA). Resultados Um total de 621 pacientes responderam ao questionário, sendo inclusos na análise 541 respostas, após a aplicação dos critérios de elegibilidade. Um total de 347 (64,14%) pacientes apresentaram disfunção sexual, sem diferença entre os gêneros. Conclusão Disfunção sexual apresenta alta prevalência no grupo estudado, sendo necessário identificar as causas e implementar estratégias de tratamento. O MSISQ-19 é uma ferramenta fácil e rápida de ser aplicada, podendo ser utilizada para facilitar a comunicação com os pacientes sobre o tema, possibilitando assim o tratamento das disfunções sexuais nessa população.
ABSTRACT
SUMMARY OBJECTIVE: This study aimed to investigate female sexual function in patients with type 1 diabetes by comparing female sexual function index scores between women with and without type 1 diabetes. METHODS: A total of 62 women with type 1 diabetes and 69 age-matched women without diabetes but with similar backgrounds were enrolled in the patient and control groups, respectively. All participants were sexually active and had no systemic diseases other than diabetes in the patient group. RESULTS: The frequency of female sexual dysfunction was significantly higher, and the mean female sexual function index score was significantly lower in women with diabetes compared to the control group (p=0.01). There was a significant relationship between sexual dysfunction and duration of diabetes, glycosylated hemoglobin test, and body mass index (p<0.05). CONCLUSION: This study demonstrates that female sexual dysfunction is more common among women with type 1 diabetes than among women without type 1 diabetes. Patients with type 1 diabetes should be evaluated in terms of sexual health. Health professionals should give more attention to and provide guidance regarding sexual function in women with type 1 diabetes.
ABSTRACT
Sexual function is a basic component of adult life quality. Studies have shown that both men and women can experience sexual dysfunction after stroke. The prevalence of post-stroke sexual dysfunction is likely to be higher than expected. This article reviews the epidemiology, influencing factors, evaluation and intervention of post-stroke sexual dysfunction.
ABSTRACT
Objective:To investigate the effects of low anterior resection syndrome (LARS) on psychological and physical function and quality of life in patients with rectal cancer.Methods:From May 2014 to May 2019, 200 patients were included. LARS scale score was adopted, and the clinical and pathological data were collected. Univariate analysis and multivariate Logistic regression analysis were performed. the European Organization for Research and Treatment of Cancer Quality of Life core questionnaire and psychological distress management screening tool survey were conducted to evaluate the quality of life and psychological state. The incidence of postoperative sexual dysfunction in male patients was analyzed.Results:The incidence of LARS was 43.0%. Multivariate analysis showed that body mass index ≥24 kg/m 2, anastomotic leakage, anastomotic distance ≤5 cm from anal margin, and preoperative radiotherapy were independent risk factors for LARS ( OR=2.123, 15.109, 7.302, 12.682, all P<0.05).The overall health level and the scores of physical function and emotional function in the functional dimension of patients in the severe LARS group were significantly lower than those in the no/mild LARS group ( t=5.788, 8.831, 8.745, all P<0.05). The scores of fatigue and diarrhea were significantly higher than those in the no/mild LARS group ( t=26.280, 49.476, all P<0.05). The psychological distress thermometer score and the scores of communication , emotional and physical problems in the severe LARS group were significantly higher than those in the no/mild LARS group ( t=4.246, 6.563, 5.913, 4.408, all P<0.05). Conclusion:LARS is a common complication after Dixon procedure for rectal cancer. Body mass index ≥24 kg/m 2, anastomotic leakage, anastomotic distance from anal margin ≤5 cm, and preoperative radiotherapy are independent risk factors for LARS.
ABSTRACT
ABSTRACT Aim: Our objective was to investigate whether there is an interaction between the COVID-19 pandemic, demographic characteristics and erectile/sexual (E/S) function in individuals from Latin America. Materials and Methods: Cross-sectional study which included Latin American individuals over 18 years old, recruited through social media and interviewed between July and August 2020 by online surveys (Google Forms) in Portuguese and Spanish languages. The E/S function was evaluated through the following questionnaires: Simplified International Index of Erectile Function (IIEF-5) and Female Sexual Function Index (FSFI); while post-traumatic stress disorder (PTSD) triggered by the COVID-19 pandemic was assessed through the Impact of Event Scale Revised (IES-R). The data was analyzed by T Student, bivariate and multivariate logistic regression, with significance determined by the Wald test (p<0.05), using the R software v4.0. Results: Out of the 2016 individuals that responded to the survey, 1986 were included and 743 of them presented E/S dysfunction. PTSD occurrence was greater among people with E/S dysfunction when compared to those without E/S dysfunction, in the total score (males: IES-R=26.54[±19.17] and females: IES-R=35.92[±19.25]) and also in the three domains. It was found that those who do not live with a partner were 74% more likely to have E/S dysfunction, but living with a partner during the pandemic had a greater impact on E/S function. Conclusion: A negative interaction between the impact of the COVID-19 pandemic and erectile/sexual function of the Latin American population was observed, with greater implications among the individuals who live with their partners.
ABSTRACT
Objective:To explore the application effect of improved urinary control technology in patients with benign prostatic hyperplasia (BPH).Methods:A total of 83 BPH patients admitted to Taihe County People′s Hospital of Anhui Province from June 2017 to August 2020 were selected and divided into the control group (41 cases) and the observation group (42 cases) by a random number table. The control group performed transurethral plasma kinetic enucleation of prostate (PKEP), and the observation group performed modified urinary control technology. The general conditions of surgery, voiding function, urinary control function, sexual function and complication rate were compared between the two groups.Results:Compared with the control group, theoperation time in the observation group was longer and the postoperative hospital stay was shorter: (78.67 ± 20.04) min vs. (69.52 ± 18.66) min, (8.64 ± 2.66) d vs. (10.95 ± 3.01) d, there were statistical differences ( P<0.05). The postvoid residual (PVR) and the maximum flow rate (Q max) in the two groups at 1 month and 3 months after operation had no significant differences ( P>0.05). The incidence of urinary incontinence in the observation group at 24 h, 1 week, and 2 weeks after extubation were lower than those in the control group: 11.90%(5/42) vs. 36.59% (15/41), 4.76%(2/42) vs. 21.95%(9/41), 2.38%(1/42) vs. 19.51%(8/41), there were statistically differences ( P<0.05). After operation for 3 months, the total incidence of adverse events in the observation group was lower than that in the control group: 4.76% (2/42) vs. 19.51% (8/41), P<0.05. Conclusions:The improved urinary control technology has a significant application effect in BPH patients. It can effectively improve the patient′s urination function, protect urinary control and sexual function.
ABSTRACT
Objetivo: evaluar la eficacia y seguridad de dos terapias hormonales sustitutivas, combinadas con testosterona, en el tratamiento del trastorno del deseo sexual hipoactivo en mujeres en climaterio. Materiales y métodos: ensayo clínico, aleatorizado, controlado, no enmascarado. Se incluyeron mujeres mayores o igual a 40 años y menores de 60 años, con útero, con actividad sexual en las últimas seis semanas, aquejadas por síntomas vasomotores, cuyo motivo de co sulta consistió en bajo deseo sexual. Se utilizó como instrumento el cuestionario Índice de Función Sexual Femenina (IFSF). Se asignaron dos grupos aleatorizados: grupo «A¼ (51 recibieron estrógenos conjugados de equinos y edroxiprogesterona más testosterona) y grupo «B¼ (54 tibolona más testosterona). El estudio fue realizado entre julio de 2015 y diciembre de 2016, en Armenia, Quindío, Colombia. Resultados: se analizó una población de 105 mujeres. La media de edad fue de 55,8 (DS±9,38) años. En la población total, al inicio del estudio, la mediana fue de 3 encuentros sexuales por mes. Al final la mediana fue de 5 encuentros sexuales por mes, (grupo «A¼ 4 encuentros y grupo «B¼ 7 encuentros, p=0,0036). Al finalizar la investigación se observó que las mujeres del grupo «B¼, mostraron puntuaciones promedias significativamente más altas en el IFSF (28,56 DS±4,63 puntos), al compararlas con las mujeres del grupo «A¼ (27,57 DS±4,32) (p<0,0001). Conclusiones: la terapia con tibolona asociada a testosterona es una opción de tratamiento efectiva en el trastorno del deseo sexual hipoactivo en mujeres en climaterio..(AU)
Objective: to evaluate the efficacy and safety of two hormone replacement therapies, combined with testosterone, in the treatment of hypoactive sexual desire disorder in women in climacteric. Materials and methods: clinical trial, randomized, controlled, not masked. Women over 40 years old and under 60 years old, with a uterus, with sexual activity in the last six weeks, suffering from vasomotor symptoms, whose reason for consultation consisted of low sexual desire were included. The Female Sexual Function Index questionnaire was used as an instrument. Two randomized groups were assigned: group "A" (51 received conjugated estrogens from equines and medroxyprogesterone plus testosterone) and group "B" (54 tibolone plus testosterone). The study was conducted between July 2015 and December 2016, in Armenia, Quindío, Colombia. Results: a population of 105 women was analyzed. The average age was 55,8 (SD ± 9,38) years. In the total population, at the beginning of the study, the median was 3 sexual encounters per month. In the end, the median was 5 sexual encounters per month, (group «A¼ 4 meetings and group «B¼ 7 meetings, p = 0,0036). At the end of the investigation, it was observed that the women of the «B¼ group showed significantly higher average scores in the IFSF (28,56 SD ± 4,63 points), compared with values in the women of the «A¼ group (27,57 DS ± 4,32) (p<0,0001). Conclusions: testosterone-associated tibolone therapy is an effective treatment option in hypoactive sexual desire disorder in women in climacteric..(AU)
Subject(s)
Female , Sexual Dysfunctions, Psychological , Hormone Replacement TherapyABSTRACT
ABSTRACT Objectives: to assess the sexual function of pregnant women and the influence of sociodemographic, obstetric, and behavioral factors on sexual dysfunction. Methods: cross-sectional study conducted with 141 pregnant women attended by the Single Health System and 120 by one private service, totaling 261 participants. A questionnaire containing sociodemographic, obstetric, and behavioral variables was applied, as well as the Female Sexual Function Index instrument, which was used to assess sexual function. Associations between variables and sexual dysfunction were made using the chi-square test, considering a statistically significant result when p < 0.05. Results: among the participants, 32.1% had sexual dysfunction, and the variables "age", "income" and "type of health service" had an influence on sexual dysfunction. The prevalence of pregnant women was between 21 and 30 years old (p < 0.001), with an income between 1 and 2 minimum wages (p = 0.048) and used the public health system network (p = 0.000). Conclusions: the factors associated with sexual dysfunction are "young pregnant women", "low income" and "attended in the public health service".
RESUMEN Objetivos: evaluar la función sexual de gestantes y la influencia de los factores sociodemográficos, obstétricos y comportamentales relacionados a la disfunción sexual. Métodos: estudio transversal realizado con 141 gestantes atendidas por el Sistema Único de Salud y 120 por el servicio privado, totalizando 261 participantes. Se ha utilizado cuestionario conteniendo variables sociodemográficas, obstétricas y comportamentales; e instrumento Female Sexual Function Index para evaluar función sexual. Las relaciones entre variables y disfunción sexual han sido realizadas por el test chi cuadrado, consideradas estadísticamente significantes si p < 0,05. Resultados: de los participantes, 32,1% presentaron disfunción sexual, y hay influencia de los factores "edad", "renta" y "tipo de servicio de salud" en la disfunción sexual, prevaleciendo gestantes entre 21 y 30 años (p < 0,001), con renta entre 1 y 2 salarios mínimos (p = 0,048) y que utilizan el servicio público (p = 0,000). Conclusiones: los factores relacionados a la disfunción sexual son "gestantes jóvenes", "baja renta" y "atención en el servicio público".
RESUMO Objetivos: avaliar a função sexual de gestantes e a influência dos fatores sociodemográficos, obstétricos e comportamentais associados à disfunção sexual. Métodos: estudo transversal realizado com 141 gestantes atendidas pelo Sistema Único de Saúde e 120 pelo serviço privado, totalizando 261 participantes. Utilizou-se questionário contendo variáveis sociodemográficas, obstétricas e comportamentais; e instrumento Female Sexual Function Index para avaliar função sexual. As associações entre variáveis e disfunção sexual foram feitas pelo teste quiquadrado, consideradas estatisticamente significativas se p < 0,05. Resultados: dos participantes, 32,1% apresentaram disfunção sexual, e há influência dos fatores "idade", "renda" e "tipo de serviço de saúde" na disfunção sexual, prevalecendo gestantes entre 21 e 30 anos (p < 0,001), com renda entre 1 e 2 salários mínimos (p = 0,048) e que utilizam o serviço público (p = 0,000). Conclusões: os fatores associados à disfunção sexual são "gestantes jovens", "baixa renda" e "atendimento no serviço público".
ABSTRACT
ABSTRACT Objectives: to assess the sexual function of pregnant women and the influence of sociodemographic, obstetric, and behavioral factors on sexual dysfunction. Methods: cross-sectional study conducted with 141 pregnant women attended by the Single Health System and 120 by one private service, totaling 261 participants. A questionnaire containing sociodemographic, obstetric, and behavioral variables was applied, as well as the Female Sexual Function Index instrument, which was used to assess sexual function. Associations between variables and sexual dysfunction were made using the chi-square test, considering a statistically significant result when p < 0.05. Results: among the participants, 32.1% had sexual dysfunction, and the variables "age", "income" and "type of health service" had an influence on sexual dysfunction. The prevalence of pregnant women was between 21 and 30 years old (p < 0.001), with an income between 1 and 2 minimum wages (p = 0.048) and used the public health system network (p = 0.000). Conclusions: the factors associated with sexual dysfunction are "young pregnant women", "low income" and "attended in the public health service".
RESUMEN Objetivos: evaluar la función sexual de gestantes y la influencia de los factores sociodemográficos, obstétricos y comportamentales relacionados a la disfunción sexual. Métodos: estudio transversal realizado con 141 gestantes atendidas por el Sistema Único de Salud y 120 por el servicio privado, totalizando 261 participantes. Se ha utilizado cuestionario conteniendo variables sociodemográficas, obstétricas y comportamentales; e instrumento Female Sexual Function Index para evaluar función sexual. Las relaciones entre variables y disfunción sexual han sido realizadas por el test chi cuadrado, consideradas estadísticamente significantes si p < 0,05. Resultados: de los participantes, 32,1% presentaron disfunción sexual, y hay influencia de los factores "edad", "renta" y "tipo de servicio de salud" en la disfunción sexual, prevaleciendo gestantes entre 21 y 30 años (p < 0,001), con renta entre 1 y 2 salarios mínimos (p = 0,048) y que utilizan el servicio público (p = 0,000). Conclusiones: los factores relacionados a la disfunción sexual son "gestantes jóvenes", "baja renta" y "atención en el servicio público".
RESUMO Objetivos: avaliar a função sexual de gestantes e a influência dos fatores sociodemográficos, obstétricos e comportamentais associados à disfunção sexual. Métodos: estudo transversal realizado com 141 gestantes atendidas pelo Sistema Único de Saúde e 120 pelo serviço privado, totalizando 261 participantes. Utilizou-se questionário contendo variáveis sociodemográficas, obstétricas e comportamentais; e instrumento Female Sexual Function Index para avaliar função sexual. As associações entre variáveis e disfunção sexual foram feitas pelo teste quiquadrado, consideradas estatisticamente significativas se p < 0,05. Resultados: dos participantes, 32,1% apresentaram disfunção sexual, e há influência dos fatores "idade", "renda" e "tipo de serviço de saúde" na disfunção sexual, prevalecendo gestantes entre 21 e 30 anos (p < 0,001), com renda entre 1 e 2 salários mínimos (p = 0,048) e que utilizam o serviço público (p = 0,000). Conclusões: os fatores associados à disfunção sexual são "gestantes jovens", "baixa renda" e "atendimento no serviço público".
ABSTRACT
Male sexual dysfunction refers to a phenomenon in which a man experiences difficulty at any stage during the process of sexual intercourse. In general, erectile dysfunction is regarded as the most representative form of sexual dysfunction, but various other diseases can also be categorized as male sexual dysfunction, including sexual arousal disorder, decreased libido, ejaculation disorder, and Peyronie's disease. Causes of sexual dysfunction include chronic diseases, such as diabetes, hypertension, dyslipidemia, and obesity. In addition, some medications, surgical procedures, and traumas can cause sexual dysfunction. However, aging is the most important cause of male sexual dysfunction. To diagnose and treat elderly patients who complain of male sexual dysfunction, it is first necessary to become familiar with the characteristics of sexual dysfunction in elderly men. The prevalence rates of metabolic syndrome, hypertension, diabetes, dyslipidemia, coronary artery disease, stroke, and depression are higher among elderly men than among younger men; furthermore, the elderly are at a higher risk for the development of kidney, hepatic, spinal cord, and neurological diseases. Notably, anti-hypertensive agents can affect erectile function in elderly men: sexual dysfunction may be severe or the response to treatment may be poor. For satisfactory treatment, spousal factors should also be considered.
Subject(s)
Aged , Humans , Male , Aging , Antihypertensive Agents , Chronic Disease , Coitus , Coronary Artery Disease , Depression , Diagnosis , Dyslipidemias , Ejaculation , Erectile Dysfunction , Eunuchism , Hypertension , Kidney , Libido , Obesity , Penile Induration , Prevalence , Sexual Dysfunction, Physiological , Sexual Dysfunctions, Psychological , Spinal Cord , Stroke , TestosteroneABSTRACT
Penile prosthesis infection is the most significant complication following prosthesis implant surgery leading to postoperative morbidity, increased health care costs, and psychological stress for the patient. We aimed to identify risk factors associated with increased postoperative penile prosthesis infection. A review of the literature was performed via PubMed using search terms including inflatable penile prosthesis, penile implant, and infection. Articles were given a level of evidence score using the 2011 Oxford Centre for Evidence-Based Medicine Guidelines. Multiple factors were associated with increased risk of post-prosthesis placement infection (Level of Evidence Rating) including smoking tobacco (Level 1), CD4 T-cell count 8.5 (Level 2). Factors with no effect on infection rate include: preoperative cleansing with antiseptic (Level 4), history of prior radiation (Level 3), history of urinary diversion (Level 4), obesity (Level 3), concomitant circumcision (Level 3), immunosuppression (Level 4), age >75 (Level 4), type of hand cleansing (Level 1), post-surgical drain placement (Level 3), and surgical approach (Level 4). Factors associated with decreased rates of infection included: surgeon experience (Level 2), “No Touch” technique (Level 3), preoperative parenteral antibiotics (Level 2), antibiotic coated devices (Level 2), and operative field hair removal with clippers (Level 1). Optimization of pre-surgical and intraoperative risk factors is imperative to reduce the rate of postoperative penile prosthesis infection. Additional research is needed to elucidate risk factors and maximize benefit.
Subject(s)
Humans , Male , Anti-Bacterial Agents , Erectile Dysfunction , Evidence-Based Medicine , Hair Removal , Hand , Health Care Costs , Immunosuppression Therapy , Obesity , Penile Prosthesis , Prostheses and Implants , Risk Factors , Sexual Dysfunction, Physiological , Smoke , Smoking , Spinal Cord Injuries , Staphylococcus aureus , Stress, Psychological , T-Lymphocytes , Tobacco , Urinary DiversionABSTRACT
Objective@#To investigate the sexual function, urinary function and quality of life in patients of ulcerative colitis(UC) and familial adenomatous polyposis(FAP) after total proctocolectomy and ileal pouch anal anastomosis (IPAA).@*Methods@#The clinical data of patients with UC and FAP undergoing IPAA at Zhongnan Hospital of Wuhan University from Jan 2006 to Sep 2018 were reviewed , postoperative sexual function, urinary function, and long-term quality of life were assessed.@*Results@#There were 45 patients with median age of 35 years , median follow-up time of 31 months. 18 were UC, 27 were FAP, 5 did 1-stage surgery, 37 did 2-stage surgery, 3 for 3-stage surgery, 13 underwent open surgery, and 32 underwent laparoscopic surgery. 7 patients suffered sexual dysfunction after IPAA, and there was no statistical difference between male and female (P=0.992), UC and FAP (P=0.153), 1-stage , 2-stage , and 3-stage surgery (P=0.363) , with statistically significant difference between the open group and the laparoscopic group (P=0.025). 6 patients complicated with urinary dysfunction after IPAA , and there was no statistical difference between male and female (P=0.562), UC and FAP (P=0.325), 1-stage, 2-stage, and 3-stage surgery (P=0.286) , with statistically significant difference between the open group and the laparoscopic group (P=0.007). The Cleveland Global Quality of Life (CGQL) score after IPAA was 0.696±0.085. There were no statistical difference on CGQL scores in males and females (P=0.635), UC and FAP (P=0.664), 1-stage, 2-stage, and 3-stage (P>0.05), open group and laparoscopic group (P=0.205), postoperative long-term QOL was significantly associated only with age at the time of surgery (P=0.001).@*Conclusions@#Compared with open surgery, laparoscopic TPC-IPAA patients had better postoperative sexual function and urination function.
ABSTRACT
Obstructive sleep apnea (OSA) is a common disorder characterized by intermittent hypoxia and sleep fragmentation. OSA in middle-aged men is often associated with decreased testosterone secretion, together with obesity and aging. Although OSA treatment does not reliably increase testosterone levels in most studies, OSA treatment with testosterone replacement therapy (TRT) may not only improve hypogonadism, but can also alleviate erectile/sexual dysfunction. However, because TRT may exacerbate OSA in some patients, patients should be asked about OSA symptoms before and after starting TRT. Furthermore, TRT should probably be avoided in patients with severe untreated OSA.
Subject(s)
Humans , Male , Aging , Hypoxia , Continuous Positive Airway Pressure , Erectile Dysfunction , Hypogonadism , Multiple Endocrine Neoplasia Type 1 , Obesity , Sexual Dysfunction, Physiological , Sleep Apnea, Obstructive , Sleep Deprivation , TestosteroneABSTRACT
Objective To investigate the sexual function,urinary function and quality of life in patients of ulcerative cohtis(UC) and familial adenomatous polyposis(FAP) after total proctocolectomy and ileal pouch anal anastomosis (IPAA).Methods The clinical data of patients with UC and FAP undergoing IPAA at Zhongnan Hospital of Wuhan University from Jan 2006 to Sep 2018 were reviewed,postoperative sexual function,urinary function,and long-term quality of life were assessed.Results There were 45 patients with median age of 35 years,median follow-up time of 31 months.18 were UC,27 were FAP,5 did 1-stage surgery,37 did 2-stage surgery,3 for 3-stage surgery,13 underwent open surgery,and 32 underwent laparoscopic surgery.7 patients suffered sexual dysfunction after IPAA,and there was no statistical difference between male and female (P =0.992),UC and FAP (P =0.153),1-stage,2-stage,and 3-stage surgery (P =0.363),with statistically significant difference between the open group and the laparoscopic group (P =0.025).6 patients complicated with urinary dysfunction after IPAA,and there was no statistical difference between male and female (P =0.562),UC and FAP (P =0.325),1-stage,2-stage,and 3-stage surgery (P =0.286),with statistically significant difference between the open group and the laparoscopic group (P =0.007).The Cleveland Global Quality of Life (CGQL) score after IPAA was 0.696 ± 0.085.There were no statistical difference on CGQL scores in males and females (P =0.635),UC and FAP (P =0.664),1-stage,2-stage,and 3-stage (P ＞ 0.05),open group and laparoscopic group (P =0.205),postoperative long-term QOL was significantly associated only with age at the time of surgery (P =0.001).Conclusions Compared with open surgery,laparoscopic TPC-IPAA patiems had better postoperative sexual function and urination function.
ABSTRACT
Resumen OBJETIVO: Determinar los efectos de la dosis oral diaria de 50 mg de dehidroepiandrosterona en la función sexual de pacientes posmenopáusicas. MATERIALES Y MÉTODOS: Estudio experimental, clínico, prospectivo y longitudinal efectuado en pacientes posmenopáusicas atendidas en el Hospital Juárez de México entre los meses de abril a julio de 2017. La muestra se seleccionó de pacientes posmenopáusicas atendidas por primera vez que cumplieran los criterios de inclusión. Administración de 50 mg de prasterona (Biolaif™) por vía oral cada 24 horas durante 12 meses a las pacientes con protocolo de estudio completo; consulta de seguimiento cada 3 meses. Estadística descriptiva y análisis bidimensional de Friedman. Los estudios estadísticos se realizaron con el programa SPSS versión 22. RESULTADOS: En 29 pacientes se evaluó el índice de función sexual que se incrementó, posterior al tratamiento oral con 50 mg diarios de prasterona, de una media de 10.8 a 28.1, y a 12 meses en 18 pacientes de una media de 10.6 a 29.1. CONCLUSIONES: La disfunción sexual es un problema de salud infradiagnosticado en pacientes posmenopáusicas. La administración oral de prasterona (dehidroepiandrosterona) a dosis de 50 mg al día mejoró todos los dominios del índice de función sexual femenina de todas las pacientes estudiadas con resultados estadísticamente significativos, sin efectos secundarios de hiperandrogenismo.
Abstract OBJECTIVE: To determine the effects of the administration of 50 mg of DHEA orally daily on sexual function of menopausal patients. MATERIALS AND METHODS: We performed an experimental, clinical, prospective and longitudinal study in menopausal patients. We selected the sample from april to july 2017 with menopausal patients who attended for the first time at the clinic who met the inclusion criteria, having a final sample of 29 patients. Patients with a complete study protocol who met the entry criteria were administered 50 mg of prasterone (Biolaif™) orally daily for 12 months, with a follow-up consultation every 3 months. Descriptive statistics were used for the statistical analysis. Also, Friedman's two-dimensional analysis was used. All statistical studies were conducted in the SPSS program, v.22. RESULTS: Sexual Function Index evaluated with 29 patients at 6 months increased from an average of 10.8 to 28.1. At 12 months with 18 patients, after the treatment with 50 mg prasterone orally daily, it increased from an average of 10.6 to 29.1. CONCLUSIONS: Sexual dysfunction is an underdiagnosed health problem in patients over the postmenopausal stage. Administration of prasterone (DHEA) at a dose of 50 mg orally daily improved the domains of Female Sexual Function Index of all our patients with statistically significant results, without side effects of hyperandrogenism.
ABSTRACT
Objetivo Verificar o entendimento acerca da atuação da fisioterapia nas disfunções do assoalho pélvico por parte dos profissionais de saúde da rede pública. Métodos Trata-se de um estudo transversal realizado com profissionais médicos e enfermeiros que trabalham nas Unidades Básicas de Saúde vinculadas ao Núcleo de Apoio à Saúde da Família 1 do município de Timbó, Santa Catarina. Por se tratar de um estudo descritivo e exploratório, os dados serão apresentados por estatística descritiva simples. Como instrumento de avaliação, foi utilizado um questionário misto criado pelas autoras abordando o conhecimento dos distúrbios cinesiológico-funcionais pélvicos humanos e da atuação da fisioterapia pélvica. Resultados A pesquisa finalizou com 13 participantes: 6 médicos e 7 enfermeiros, que demonstraram conhecer as disfunções do assoalho pélvico, assim como a atuação da fisioterapia pélvica. Conclusão A maioria dos profissionais assinalou conhecer a atuação da fisioterapia pélvica e desses, a maioria se deu através do contato com fisioterapeutas da rede. Os motivos mais frequentes de encaminhamentos listados pelos médicos são a incontinência urinária, prolapsos genitais, disfunções sexuais, gravidez e disfunções anorretais.
Objective To verify the understanding about the performance of physiotherapy in pelvic floor dysfunctions by public health care professionals. Methods This is a cross-sectional study carried out with medical professionals and nurses working at the Basic Health Care Units linked to the Family Health Support Center - 1 in the city of Timbó, Santa Catarina, Brazil. As it is a descriptive and exploratory study, data will be presented by simple descriptive statistics. As an evaluation tool, a mixed questionnaire was created by the authors addressing the knowledge of human pelvic kinesiologicalfunctional disorders and the performance of pelvic physiotherapy. Results The research was performed with 13 volunteers: 6 physicians and 7 nurses, who demonstrated to have a good understanding about pelvic floor dysfunctions, as well as about the performance of pelvic physiotherapy. Conclusion Most of the professionals indicated that they had a good understanding about the performance of pelvic physiotherapy and of these, most of them acquired it through the contact with physiotherapists of the public health care system. The most common reasons for referrals listed by physicians are urinary incontinence, genital prolapse, sexual dysfunction, pregnancy, and anorectal dysfunction.
Subject(s)
Humans , Sexual Dysfunction, Physiological , Urinary Incontinence , Public Health , Pelvic Floor , Physical Therapy SpecialtyABSTRACT
No pós-parto, pode haver dor durante a relação sexual e disfunções do assoalho pélvico, que são associadas ao parto vaginal pela possibilidade de lesões perineais ou episiotomia, levando a indicações de cesariana eletiva como fator de proteção da função sexual. Assim, este estudo propõe analisar a relação entre parto por vaginal ou cesárea e a presença de dispareunia no período pós-parto. Foi realizada uma revisão integrativa nas bases de dados Lilacs e PubMed utilizando os descritores "Sexual Dysfunction, Physiological" e "Postpartum Period". Foram encontrados 28 artigos, sendo incluídos 13 por se encaixarem nos critérios de elegibilidade. Os resultados mostraram que a dispareunia pode ocorrer em 24,0 a 85,7% das puérperas. Após o primeiro parto vaginal, 21,0% apresentam avulsão dos levantadores do ânus, mas 62,0% não são evidentes após um ano. A alteração do corpo perineal não está relacionada a laceração ou a função sexual, mas 32,5% das mulheres que relataram dor perineal no primeiro mês relataram dispareunia aos 6 meses. 85,7% relatam dor na primeira relação pós-parto e as que tiveram cesariana foram mais propensas a dispareunia seis meses após o parto. 31,5% das lactantes aos 6 meses e 24,1 a 28,3% das que apresentaram queixas psicossocias relataram dispareunia. Concluiu-se que a disfunção sexual pode ocorrer nos primeiros meses tanto no pós-parto por via vaginal quanto cesariana, mas após o primeiro ano do parto, a função sexual parece se restabelecer independente da via de parto, com exceção dos traumas perineais severos.
In the postpartum period there may be pain during sexual intercourse and pelvic floor dysfunctions related to vaginal delivery due to the possibility of perineal tears or episiotomy and suggesting a protective effect of elective cesarean section on sexual function. Thus, this study proposes to examine the relationship between vaginal delivery or elective cesarean section and the presence of dyspareunia in the postpartum period. A integrative review was carried out in the Lilacs and PubMed databases using the descriptors "Sexual Dysfunction, Physiological" and "Postpartum Period". Twenty-eight articles were found, with 13 being included because they fit the eligibility criteria. The results showed that the dyspareunia can occur in 24.0 to 85.7% of puerperal women. After the first vaginal delivery, 21.0% had levator ani avulsion injury, but 62.0% are not evident after one year. Alteration of the perineal body is not related to laceration or sexual function, but 32.5% of women reporting perineal pain in the first month reported dyspareunia at 6 months. Another 85.7% reported pain in the first postpartum sexual intercourse and those who had cesarean section had more risk for dyspareunia up to six months after delivery. A total of 31.5% of women who breastfeed at 6 months and between 24.1 and 28.3% of those who presented psychosocial complaints reported cases of dyspareunia. It was concluded that the sexual dysfunction may occur in the first few months after delivery, either both vaginal or cesarean, but after the first year of delivery, sexual function seems to be restored regardless of the mode of delivery, with the exception of severe perineal traumas.
Subject(s)
Humans , Female , Sexual Dysfunction, Physiological , Postpartum Period , Dyspareunia , Cesarean Section , Natural ChildbirthABSTRACT
Abstract: Background: Psoriasis has a significant impact on quality of life (QoL). Sexual life can also be affected, with sexual dysfunction being reported by 25-70% of patients. Objectives: To determine the occurrence of sexual dysfunction and evaluate QoL in women with psoriasis. Methods: This case-control study included women aged 18-69 years. The validated Brazilian Portuguese versions of the Female Sexual Function Index (FSFI) and of the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) were administered to all participants to assess sexual function and QoL, respectively. Patients with psoriasis underwent clinical evaluation for the presence of comorbidities, especially psoriatic arthritis and other rheumatic manifestations. Location of lesions and the extent of skin involvement were also assessed. Results: The sample consisted of 150 women, 75 with diagnosis of psoriasis and 75 healthy controls. Prevalence of sexual dysfunction was high in women with psoriasis (58.6% of the sample). Prevalence was statistically higher in women with psoriasis than in controls (P = 0.014). The SF-36 domain scores were also lower in women with psoriasis, with role limitations due to physical health, limitations due to emotional problems, and mental health being the most affected domains. Study limitations: Sample size was calculated to evaluate the association between the occurrence of sexual dysfunction and psoriasis, but it did not include the determination of the possible causes of this dysfunction. Conclusions: QoL and sexual function were altered in women with psoriasis and should be taken into consideration when assessing disease severity.
Subject(s)
Humans , Female , Adolescent , Adult , Middle Aged , Aged , Young Adult , Psoriasis/psychology , Quality of Life/psychology , Sexual Dysfunctions, Psychological/psychology , Psoriasis/complications , Psoriasis/epidemiology , Severity of Illness Index , Brazil/epidemiology , Case-Control Studies , Prevalence , Surveys and Questionnaires , Sexual Dysfunctions, Psychological/epidemiologyABSTRACT
OBJECTIVES: The goal of this study was to explore perceptions and experiences of general practitioners and midwives during sexual dialogue with menopausal women. METHODS: In a descriptive exploratory qualitative study, 13 midwives and 12 general practitioners were selected using a semi-structured interview and purposive sampling method. Data analysis was conducted using qualitative content analysis adopted by Graneheim and Lundman. RESULTS: Through data analysis “sexual disharmony” emerged as a central theme, which included three categories of reasons, strategies, and ramifications of sexual disharmony. Reasons for sexual disharmony included subcategories of aging and health related-problems, marital problems, and stereotypical perceptions regarding menopause and sexuality and daily concerns. Strategies used by couples to address sexual disharmony consisted of changing roles and values, pretending to reach orgasm, suppressing sexual desire, meeting sexual needs of husbands in accordance with religious rules, seeking help of peers, seeking friends or traditional medicine and health providers, seeking a help charmer, engaging in sex with other women to fulfill sexual needs, pretending to be moody to alleviate sexual tension. Sexual disharmony may lead to spending money on a prostitute instead of engaging in sex out of wedlock or a surge in social pathologies such as sexually transmitted disease. CONCLUSIONS: Healthcare providers must be aware of various sexual behavior of menopausal women and their husbands when they detect sexual disharmony in their patients. Results of this study can facilitate development of restricted guidelines for sexual discussion with menopausal women.